|
US20030105294A1
(en)
*
|
1998-02-25 |
2003-06-05 |
Stephen Gillies |
Enhancing the circulating half life of antibody-based fusion proteins
|
|
US20050202538A1
(en)
*
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
|
HUP0204475A2
(en)
|
2000-02-11 |
2003-04-28 |
Merck Patent Gmbh |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
AU2002248571B2
(en)
|
2001-03-07 |
2007-01-18 |
Merck Patent Gmbh |
Expression technology for proteins containing a hybrid isotype antibody moiety
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
PT1383785E
(pt)
|
2001-05-03 |
2011-06-28 |
Merck Patent Gmbh |
Anticorpo recombinante específico de tumores e utilização deste
|
|
PT1454138E
(pt)
|
2001-12-04 |
2012-03-28 |
Merck Patent Gmbh |
Imunocitoquinas com seletividade modulada
|
|
CA2551915C
(en)
*
|
2003-12-30 |
2015-06-23 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Il-7 fusion proteins
|
|
JP2008504008A
(ja)
*
|
2003-12-31 |
2008-02-14 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改良された薬物動態を有するＦｃ−エリスロポエチン融合タンパク質
|
|
US7670595B2
(en)
*
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
US20070104689A1
(en)
*
|
2005-09-27 |
2007-05-10 |
Merck Patent Gmbh |
Compositions and methods for treating tumors presenting survivin antigens
|
|
AR058135A1
(es)
|
2005-10-21 |
2008-01-23 |
Chugai Pharmaceutical Co Ltd |
Agentes para el tratamiento de cardiopatias
|
|
WO2007076927A1
(en)
|
2005-12-30 |
2007-07-12 |
Merck Patent Gmbh |
Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
|
|
EP2025346B1
(en)
|
2006-04-07 |
2016-08-10 |
Osaka University |
Muscle regeneration promoter
|
|
TW200831528A
(en)
|
2006-11-30 |
2008-08-01 |
Astrazeneca Ab |
Compounds
|
|
US8153128B2
(en)
*
|
2006-11-30 |
2012-04-10 |
Medimmune Limited |
Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor
|
|
WO2008090901A1
(ja)
|
2007-01-23 |
2008-07-31 |
Shinshu University |
慢性拒絶反応抑制剤
|
|
US8252286B2
(en)
|
2007-05-21 |
2012-08-28 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
US9701747B2
(en)
|
2007-05-21 |
2017-07-11 |
Alderbio Holdings Llc |
Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
|
|
US8404235B2
(en)
|
2007-05-21 |
2013-03-26 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
US7906117B2
(en)
|
2007-05-21 |
2011-03-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
|
|
US8178101B2
(en)
|
2007-05-21 |
2012-05-15 |
Alderbio Holdings Inc. |
Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
|
|
HUE032563T2
(en)
|
2007-05-21 |
2017-09-28 |
Alderbio Holdings Llc |
Antibodies to IL-6 and their use
|
|
US8062864B2
(en)
|
2007-05-21 |
2011-11-22 |
Alderbio Holdings Llc |
Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
|
|
WO2009109584A1
(en)
*
|
2008-03-07 |
2009-09-11 |
Ferring International Center S. A. |
ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX
|
|
WO2009140348A2
(en)
|
2008-05-13 |
2009-11-19 |
Novimmune Sa |
Anti-il-6/il-6r antibodies and methods of use thereof
|
|
TWI528973B
(zh)
|
2008-06-05 |
2016-04-11 |
Chugai Pharmaceutical Co Ltd |
Nerve infiltration inhibitor
|
|
US8188235B2
(en)
*
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
|
EA019512B1
(ru)
*
|
2008-07-02 |
2014-04-30 |
Эмерджент Продакт Дивелопмент Сиэтл, Ллс |
Il-6-опосредованная иммунотерапия
|
|
AU2009296937B2
(en)
*
|
2008-09-29 |
2015-02-12 |
Centocor Ortho Biotech Inc. |
Anti-CD147 antibodies, methods, and uses
|
|
US8337847B2
(en)
|
2008-11-25 |
2012-12-25 |
Alderbio Holdings Llc |
Methods of treating anemia using anti-IL-6 antibodies
|
|
US9212223B2
(en)
|
2008-11-25 |
2015-12-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
|
US8323649B2
(en)
|
2008-11-25 |
2012-12-04 |
Alderbio Holdings Llc |
Antibodies to IL-6 and use thereof
|
|
US8420089B2
(en)
|
2008-11-25 |
2013-04-16 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
|
US8992920B2
(en)
|
2008-11-25 |
2015-03-31 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of arthritis
|
|
CA2744400C
(en)
*
|
2008-11-25 |
2019-01-15 |
Alder Biopharmaceuticals, Inc. |
Antibodies to il-6 and use thereof
|
|
US9452227B2
(en)
|
2008-11-25 |
2016-09-27 |
Alderbio Holdings Llc |
Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
|
|
EP2421896A1
(en)
|
2009-04-22 |
2012-02-29 |
Merck Patent GmbH |
Antibody fusion proteins with modified fcrn binding sites
|
|
EP2998405B1
(en)
|
2009-05-13 |
2019-12-11 |
Genzyme Corporation |
Anti-human cd52 immunoglobulins
|
|
EP2464666B1
(en)
*
|
2009-07-15 |
2018-03-21 |
Eva Kovacs-Benke |
Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases
|
|
AU2010278067B2
(en)
*
|
2009-07-31 |
2016-10-27 |
Shin Maeda |
Cancer metastasis inhibitor
|
|
ES2622487T3
(es)
*
|
2009-08-19 |
2017-07-06 |
Merck Patent Gmbh |
Anticuerpos para la detección de complejos de integrina en material FFPE
|
|
US9775921B2
(en)
|
2009-11-24 |
2017-10-03 |
Alderbio Holdings Llc |
Subcutaneously administrable composition containing anti-IL-6 antibody
|
|
WO2011066374A2
(en)
|
2009-11-24 |
2011-06-03 |
Alder Biopharmaceuticals, Inc. |
Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
|
|
US20130052195A1
(en)
|
2009-12-23 |
2013-02-28 |
Emergent Product Development Seattle,LLC |
Compositions Comprising TNF-alpha and IL-6 Antagonists and Methods of Use Thereof
|
|
JP6051049B2
(ja)
|
2010-05-28 |
2016-12-21 |
中外製薬株式会社 |
抗腫瘍ｔ細胞応答増強剤
|
|
US9304134B2
(en)
|
2010-11-23 |
2016-04-05 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of anemia
|
|
US20140255405A1
(en)
|
2011-05-27 |
2014-09-11 |
Dutalys |
Removal of Monomeric Targets
|
|
EP2723380B1
(en)
|
2011-06-24 |
2019-08-21 |
Stephen D. Gillies |
Light chain immunoglobulin fusion proteins and methods of use thereof
|
|
US20140315956A1
(en)
*
|
2011-07-29 |
2014-10-23 |
Nationwide Children's Hospital |
Small molecule inhibitors of il-6 and uses thereof
|
|
WO2013059548A1
(en)
*
|
2011-10-19 |
2013-04-25 |
Sanofi |
Compositions and methods for treating cancer using jak2 inhibitor
|
|
BR112015010360A8
(pt)
*
|
2012-11-08 |
2018-01-16 |
Eleven Biotherapeutics Inc |
antagonistas de il-6 e utilização dos mesmos.
|
|
US9816989B2
(en)
|
2013-03-12 |
2017-11-14 |
Institute of Arthritis Research, LLC |
Immunologically active polypeptide
|
|
AR095199A1
(es)
|
2013-03-15 |
2015-09-30 |
Genzyme Corp |
Anticuerpos anti-cd52
|
|
ES2915378T3
(es)
|
2013-09-13 |
2022-06-22 |
Hoffmann La Roche |
Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares
|
|
EP4331605A3
(en)
|
2013-09-13 |
2024-05-22 |
F. Hoffmann-La Roche AG |
Methods and compositions comprising purified recombinant polypeptides
|
|
CN103897061B
(zh)
*
|
2014-03-25 |
2017-06-16 |
宝船生物医药科技(上海)有限公司 |
阻断西妥昔单抗和egfr结合的抗体、其试剂盒及杂交瘤细胞
|
|
TWI713453B
(zh)
|
2014-06-23 |
2020-12-21 |
美商健生生物科技公司 |
干擾素α及ω抗體拮抗劑
|
|
PT3215530T
(pt)
*
|
2014-11-07 |
2019-11-21 |
Sesen Bio Inc |
Anticorpos de il-6 melhorados
|
|
LT3226888T
(lt)
*
|
2014-12-01 |
2021-05-25 |
Ferring B.V. |
Selektyvaus il-6-trans-signalinio inhibitoriaus skyrimas
|
|
RS65665B1
(sr)
*
|
2014-12-01 |
2024-07-31 |
Ferring Bv |
Selektivne kompozicije inhibitora il-6-trans-signalizacije
|
|
TWI763630B
(zh)
|
2015-07-02 |
2022-05-11 |
瑞士商赫孚孟拉羅股份公司 |
雙環內醯胺及其使用方法
|
|
EP3419599A4
(en)
|
2016-02-23 |
2019-09-11 |
Sesen Bio, Inc. |
IL-6 ANTAGONIST FORMULATIONS AND USE THEREOF
|
|
EP3526219B1
(en)
|
2016-10-17 |
2021-12-15 |
F. Hoffmann-La Roche AG |
Bicyclic pyridone lactams and methods of use thereof
|
|
US11072607B2
(en)
|
2016-12-16 |
2021-07-27 |
Genentech, Inc. |
Inhibitors of RIP1 kinase and methods of use thereof
|
|
KR20200012823A
(ko)
|
2017-02-01 |
2020-02-05 |
예일 유니버시티 |
이뇨제 내성의 치료
|
|
EP3620531A4
(en)
|
2017-05-02 |
2021-03-17 |
National Center of Neurology and Psychiatry |
METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS
|
|
EP3698808B1
(en)
|
2017-10-20 |
2025-01-01 |
Hyogo College Of Medicine |
Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
|
|
CN109867723B
(zh)
*
|
2017-12-05 |
2022-06-17 |
南京金斯瑞生物科技有限公司 |
抗人il6单克隆抗体及其制备方法和用途
|
|
CA3087699A1
(en)
|
2018-01-05 |
2019-07-11 |
Corvidia Therapeutics, Inc. |
Methods for treating il-6 mediated inflammation without immunosuppression
|
|
WO2019151418A1
(ja)
|
2018-01-31 |
2019-08-08 |
元一 加藤 |
Ｉｌ－６阻害剤を含有する喘息の治療剤
|
|
WO2019204537A1
(en)
|
2018-04-20 |
2019-10-24 |
Genentech, Inc. |
N-[4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol e-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs)
|
|
IL287220B2
(en)
|
2019-04-17 |
2026-03-01 |
Univ Hiroshima |
A therapeutic agent for urological cancer characterized by administering an IL-6 inhibitor in combination with a CCR2 inhibitor
|
|
US20200405883A1
(en)
|
2019-06-20 |
2020-12-31 |
Baxalta Incorporated |
Method of treatment with viral-based gene therapy
|
|
CN111057152B
(zh)
*
|
2019-12-11 |
2022-03-11 |
中国人民解放军第四军医大学 |
一种抗人IL-6Ra单克隆抗体及其应用
|
|
JP2023042974A
(ja)
*
|
2021-09-15 |
2023-03-28 |
シスメックス株式会社 |
抗サイトカイン抗体の抗原に対する親和性を向上させる方法、抗サイトカイン抗体の製造方法及び抗サイトカイン抗体
|
|
CN119080929B
(zh)
*
|
2023-06-05 |
2025-08-12 |
东莞市朋志生物科技有限公司 |
抗白介素6抗体、检测白介素6的试剂和试剂盒
|